Isoacné (Isotretinoin)

Isotretinoin binds to nuclear retinoic acid receptors, altering gene transcription that leads to smaller sebaceous glands, reduced sebum output, normalization of follicular keratinization, and anti‑inflammatory actions. These combined effects address the primary pathogenic factors of acne.

The specific dose of Isoacné is determined by the prescribing clinician based on the patient’s weight, severity of acne, and laboratory monitoring. Dosage adjustments are made to balance efficacy with safety, and patients should follow the prescriber’s instructions precisely.

Isoacné is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to a high risk of fetal malformations. It is also not recommended while breastfeeding because isotretinoin can be excreted in breast milk and may affect the infant.

To request Isoacné, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with oral antibiotics such as doxycycline, isotretinoin provides a disease‑modifying effect rather than merely suppressing bacterial growth. It offers longer‑term remission but carries a higher risk profile, requiring careful monitoring. Topical retinoids act locally, whereas isotretinoin works systemically on sebaceous gland activity.

Isoacné should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Maintaining these conditions preserves drug stability and potency throughout its shelf life.

Isoacné is taken orally, usually with a meal or a glass of milk to reduce gastrointestinal irritation. The tablet should be swallowed whole with water and not crushed or chewed. Patients should adhere to the dosing schedule set by their healthcare provider.

The most critical risks include teratogenicity, severe depression or suicidal thoughts, inflammatory bowel disease exacerbation, and significant elevations in triglycerides or liver enzymes that can lead to pancreatitis or hepatic injury. Prompt medical attention is required if any of these occur.

Isoacné is contraindicated in pregnant or nursing women, patients with known hypersensitivity to isotretinoin or other retinoids, individuals with active liver disease, uncontrolled hyperlipidemia, or those taking high‑dose vitamin A supplements. A thorough medical evaluation is essential before initiating therapy.